We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States. It targets and develops traditional Chinese medicines (TCM) in the form of single herbs ...

(RTTNews) - Bio-Techne Corp. (TECH) revealed earnings for first quarter that decreased from the same period last year but beat the Street estimates. The company's earnings totaled $33.60 million ...

Learn about Bio India Biological Corporation in Hyderabad, Telangana.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location.

Bio-Convert ApS, a Denmark-based clinical-stage biopharmaceutical company, is aiming to revolutionize the treatment of oral leukoplakia, by minimizing or removing oral leukoplakia lesions, that ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Biotech company RSC Bio Solutions has launched its FUTERRA Compressor Oils, which are synthetic lubricants designed to meet the performance demands of industrial and marine sectors. According to the ...

On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold ...

Bio-Techne's estimated fair value is US$68.96 ... run through one way of estimating the intrinsic value of Bio-Techne Corporation (NASDAQ:TECH) by projecting its future cash flows and then ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.